Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 464

1.

Morbid obesity: potential effects of hormonal contraception.

Stanczyk FZ, Burke AE, Hong KM, Archer DF.

Contraception. 2018 May 16. pii: S0010-7824(18)30184-7. doi: 10.1016/j.contraception.2018.05.008. [Epub ahead of print] No abstract available.

PMID:
29777662
2.

Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.

Pérez-Caraballo AM, Ma Y, Ockene JK, Reeves KW, Balasubramanian R, Stanczyk FZ, Allison MA, Chen C, Wang L, Manson JE, Sturgeon SR.

Chronobiol Int. 2018 May 11:1-7. doi: 10.1080/07420528.2018.1461109. [Epub ahead of print]

PMID:
29750588
3.

Endocrine mechanisms and assay issues in premature progesterone elevation in assisted reproductive technology.

de Ziegler D, Andersen CY, Stanczyk FZ, Ayoubi JM.

Fertil Steril. 2018 Apr;109(4):571-576. doi: 10.1016/j.fertnstert.2018.02.137. Review.

PMID:
29653702
4.

Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.

Chu LW, John EM, Yang B, Kurian AW, Zia Y, Yu K, Ingles SA, Stanczyk FZ, Hsing AW.

PLoS One. 2018 Apr 11;13(4):e0195666. doi: 10.1371/journal.pone.0195666. eCollection 2018.

5.

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.

Brooks JD, Sung JS, Pike MC, Orlow I, Stanczyk FZ, Bernstein JL, Morris EA.

Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31370. [Epub ahead of print]

PMID:
29524207
6.
7.

Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).

Morimoto LM, Zava D, McGlynn KA, Stanczyk FZ, Kang AY, Ma X, Wiemels JL, Metayer C.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):488-495. doi: 10.1158/1055-9965.EPI-17-0879. Epub 2018 Feb 23.

PMID:
29475970
8.

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC.

PLoS One. 2017 Dec 27;12(12):e0187741. doi: 10.1371/journal.pone.0187741. eCollection 2017.

9.

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Tang L, Platek ME, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JKV, Santella RM, Hsing A, Figg WD, Lippman SM, Thompson IM, Ambrosone CB.

Carcinogenesis. 2018 Feb 9;39(2):125-133. doi: 10.1093/carcin/bgx144.

PMID:
29228205
10.

Determinants of prolactin in postmenopausal Chinese women in Singapore.

Katz TA, Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM, Oesterreich S, Butler LM.

Cancer Causes Control. 2018 Jan;29(1):51-62. doi: 10.1007/s10552-017-0978-8. Epub 2017 Nov 9.

11.

Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.

Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD.

JAMA. 2017 Oct 10;318(14):1367-1376. doi: 10.1001/jama.2017.14588.

12.

Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.

Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB.

Prostate. 2017 Dec;77(16):1573-1582. doi: 10.1002/pros.23433. Epub 2017 Oct 2.

PMID:
28971497
13.

Endogenous sex hormone exposure and repetitive element DNA methylation in healthy postmenopausal women.

Boyne DJ, Friedenreich CM, McIntyre JB, Stanczyk FZ, Courneya KS, King WD.

Cancer Causes Control. 2017 Dec;28(12):1369-1379. doi: 10.1007/s10552-017-0958-z. Epub 2017 Sep 19.

PMID:
28929436
14.

Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.

Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1660-1666. doi: 10.1158/1055-9965.EPI-17-0215. Epub 2017 Aug 22.

PMID:
28830872
15.

Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.

Murphy G, Cross AJ, Dawsey SM, Stanczyk FZ, Kamangar F, Weinstein SJ, Taylor PR, Männistö S, Albanes D, Abnet CC, Freedman ND.

Gut. 2017 Aug 16. pii: gutjnl-2016-313157. doi: 10.1136/gutjnl-2016-313157. [Epub ahead of print]

16.

Associations between postmenopausal endogenous sex hormones and C-reactive protein: a clearer picture with regional adiposity adjustment?

Conroy SM, Neilson HK, O'Reilly R, Woolcott CG, Stanczyk FZ, Courneya KS, Friedenreich CM.

Menopause. 2017 Sep;24(9):1040-1048. doi: 10.1097/GME.0000000000000883.

PMID:
28640164
17.

Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).

Diamandis EP, Stanczyk FZ, Wheeler S, Mathew A, Stengelin M, Nikolenko G, Glezer EN, Brown MD, Zheng Y, Chen YH, Wu HL, Azziz R.

Clin Chem Lab Med. 2017 Oct 26;55(11):1789-1797. doi: 10.1515/cclm-2016-1124.

18.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.

Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL.

Breast Cancer Res. 2017 Jan 19;19(1):8. doi: 10.1186/s13058-016-0791-4.

19.

Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women?

Maskarinec G, Ju D, Morimoto Y, Franke AA, Stanczyk FZ.

Nutr Cancer. 2017 Jan;69(1):146-153. doi: 10.1080/01635581.2017.1250924. Epub 2016 Dec 5.

20.

Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk.

Houghton LC, Ganmaa D, Rosenberg PS, Davaalkham D, Stanczyk FZ, Hoover RN, Troisi R.

Int J Environ Res Public Health. 2016 Oct 31;13(11). pii: E1066.

21.

Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).

Thurston RC, Johnson BD, Shufelt CL, Braunstein GD, Berga SL, Stanczyk FZ, Pepine CJ, Bittner V, Reis SE, Thompson DV, Kelsey SF, Sopko G, Bairey Merz CN.

Menopause. 2017 Feb;24(2):126-132. doi: 10.1097/GME.0000000000000731.

22.

Does the type of progestin influence the production of clotting factors?

Stanczyk FZ, Mathews BW, Cortessis VK.

Contraception. 2017 Feb;95(2):113-116. doi: 10.1016/j.contraception.2016.07.007. Epub 2016 Jul 13. No abstract available.

PMID:
27421764
23.

Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.

Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ.

Neurology. 2016 Aug 16;87(7):699-708. doi: 10.1212/WNL.0000000000002980. Epub 2016 Jul 15.

24.

Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.

Merz CN, Shaw LJ, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-DeHoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ.

J Womens Health (Larchmt). 2016 Sep;25(9):875-81. doi: 10.1089/jwh.2015.5441. Epub 2016 Jun 6.

25.

The Effect of Reduced Dietary Fat and Soy Supplementation on Circulating Adipocytokines in Postmenopausal Women: A Randomized Controlled 2-Month Trial.

Nadadur M, Stanczyk FZ, Tseng CC, Kim L, Wu AH.

Nutr Cancer. 2016 May-Jun;68(4):554-9. doi: 10.1080/01635581.2016.1158294. Epub 2016 May 4.

PMID:
27145207
26.

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP; ELITE Research Group.

N Engl J Med. 2016 Mar 31;374(13):1221-31. doi: 10.1056/NEJMoa1505241.

27.

The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy.

Cherala G, Edelman A, Dorflinger L, Stanczyk FZ.

Contraception. 2016 Aug;94(2):104-8. doi: 10.1016/j.contraception.2016.03.010. Epub 2016 Mar 18. No abstract available.

PMID:
27000997
28.

In Reply.

Stanczyk FZ.

Menopause. 2016 Apr;23(4):472-3. doi: 10.1097/GME.0000000000000639. No abstract available.

PMID:
26908207
29.

The impact of short-term depot-medroxyprogesterone acetate treatment on resting metabolic rate.

Steward RG, Bateman LA, Slentz C, Stanczyk FZ, Price TM.

Contraception. 2016 Apr;93(4):317-322. doi: 10.1016/j.contraception.2016.01.001. Epub 2016 Jan 6.

PMID:
26772904
30.

Inflammatory Marker Changes in Postmenopausal Women after a Year-long Exercise Intervention Comparing High Versus Moderate Volumes.

Friedenreich CM, O'Reilly R, Shaw E, Stanczyk FZ, Yasui Y, Brenner DR, Courneya KS.

Cancer Prev Res (Phila). 2016 Feb;9(2):196-203. doi: 10.1158/1940-6207.CAPR-15-0284. Epub 2015 Nov 24.

31.

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.

Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM.

Cancer Causes Control. 2016 Feb;27(2):175-82. doi: 10.1007/s10552-015-0695-0. Epub 2015 Nov 20.

32.

Effect of intravaginal dehydroepiandrosterone treatment on the endometrium: should androstenediol be a concern?

Stanczyk FZ.

Menopause. 2015 Dec;22(12):1273-5. doi: 10.1097/GME.0000000000000558. No abstract available.

PMID:
26554883
33.

Dry eye in postmenopausal women: a hormonal disorder.

Sriprasert I, Warren DW, Mircheff AK, Stanczyk FZ.

Menopause. 2016 Mar;23(3):343-51. doi: 10.1097/GME.0000000000000530. Review.

PMID:
26529614
34.

Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent.

Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, Tang Y, Yen HY, Stanczyk FZ, Enbom E, Austria T, Widschwendter M, Maxson R, Dubeau L.

PLoS One. 2015 Oct 21;10(10):e0139013. doi: 10.1371/journal.pone.0139013. eCollection 2015.

35.

Endogenous Sex Steroid Hormones, Lipid Subfractions, and Ectopic Adiposity in Asian Indians.

Kim C, Kong S, Krauss RM, Stanczyk FZ, Reddy ST, Needham BL, Kanaya AM.

Metab Syndr Relat Disord. 2015 Dec;13(10):445-52. doi: 10.1089/met.2015.0063. Epub 2015 Oct 2.

36.

Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry.

Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):56-62. doi: 10.1016/j.jsbmb.2015.09.032. Epub 2015 Sep 28.

37.

Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry.

Trabert B, Falk RT, Stanczyk FZ, McGlynn KA, Brinton LA, Xu X.

Horm Mol Biol Clin Investig. 2015 Sep;23(3):79-84. doi: 10.1515/hmbci-2015-0026.

38.

Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial.

Friedenreich CM, Neilson HK, Wang Q, Stanczyk FZ, Yasui Y, Duha A, MacLaughlin S, Kallal C, Forbes CC, Courneya KS.

Endocr Relat Cancer. 2015 Oct;22(5):863-76. doi: 10.1530/ERC-15-0243.

39.

Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?".

Stanczyk FZ, Bhavnani BR.

J Steroid Biochem Mol Biol. 2015 Sep;153:151-9. doi: 10.1016/j.jsbmb.2015.08.013. Epub 2015 Aug 19. Review.

PMID:
26291834
40.

A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.

Murphy N, Strickler HD, Stanczyk FZ, Xue X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD, Gunter MJ.

J Natl Cancer Inst. 2015 Aug 1;107(10). pii: djv210. doi: 10.1093/jnci/djv210. Print 2015 Oct.

41.

Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.

Sriprasert I, Stanczyk FZ, Archer DF.

Expert Opin Pharmacother. 2015;16(12):1901-9. doi: 10.1517/14656566.2015.1056733.

PMID:
26194214
42.

Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?

Burks HR, Ross L, Opper N, Paulson E, Stanczyk FZ, Chung K.

Fertil Steril. 2015 Sep;104(3):643-8. doi: 10.1016/j.fertnstert.2015.06.018. Epub 2015 Jul 6.

PMID:
26158904
43.

Adolescent endogenous sex hormones and breast density in early adulthood.

Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton NM, Klifa CC, Lasser NL, LeBlanc ES, Paris K, Shepherd JA, Snetselaar LG, Stanczyk FZ, Stevens VJ, Dorgan JF.

Breast Cancer Res. 2015 Jun 4;17:77. doi: 10.1186/s13058-015-0581-4.

44.

Association of estrogen measurements in serum and urine of premenopausal women.

Maskarinec G, Beckford F, Morimoto Y, Franke AA, Stanczyk FZ.

Biomark Med. 2015;9(5):417-24. doi: 10.2217/bmm.15.10.

45.

CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.

Sciaranghella G, Wang C, Hu H, Anastos K, Merhi Z, Nowicki M, Stanczyk FZ, Greenblatt RM, Cohen M, Golub ET, Watts DH, Alter G, Young MA, Tsibris AM.

J Infect Dis. 2015 Nov 1;212(9):1397-401. doi: 10.1093/infdis/jiv233. Epub 2015 Apr 20.

46.

Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk.

Nichols HB, Baird DD, Stanczyk FZ, Steiner AZ, Troester MA, Whitworth KW, Sandler DP.

Cancer Prev Res (Phila). 2015 Jun;8(6):528-34. doi: 10.1158/1940-6207.CAPR-14-0377. Epub 2015 Apr 14.

47.

Measuring Estrogen Exposure and Metabolism: Workshop Recommendations on Clinical Issues.

Demers LM, Hankinson SE, Haymond S, Key T, Rosner W, Santen RJ, Stanczyk FZ, Vesper HW, Ziegler RG; Endocrine Society; PATH (Partnership for Accurate Testing of Hormones); AACC (American Association for Clinical Chemistry).

J Clin Endocrinol Metab. 2015 Jun;100(6):2165-70. doi: 10.1210/jc.2015-1040. Epub 2015 Apr 7. No abstract available.

48.

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease.

Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Ambrosone CB, Thompson IM.

Urology. 2015 Mar;85(3):616-20. doi: 10.1016/j.urology.2014.11.024.

49.

Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science.

Stanczyk FZ, Mathews BW, Sherman ME.

Steroids. 2015 Jul;99(Pt A):91-102. doi: 10.1016/j.steroids.2014.12.011. Epub 2014 Dec 30. Review.

PMID:
25554581
50.

Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA).

Friedenreich CM, MacLaughlin S, Neilson HK, Stanczyk FZ, Yasui Y, Duha A, Lynch BM, Kallal C, Courneya KS.

BMC Cancer. 2014 Dec 6;14:919. doi: 10.1186/1471-2407-14-919.

Supplemental Content

Loading ...
Support Center